Vikram Arya

1.4k citations

50 papers · 1.1k indexed · h-index 18

Impact in

Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
Pediatrics, Perinatology and Child Health top 5%
- Pharmacological Effects and Toxicity Studies

Papers in ⓘ

Pediatrics, Perinatology and Child Health 17
- Pharmacological Effects and Toxicity Studies 12
- Pharmaceutical studies and practices 5
Pharmacology 17
- Pharmacogenetics and Drug Metabolism 15

Co-authors: Günther Hochhaus (10 shared papers)Kenta Yoshida (2 shared papers)Lei Zhang (3 shared papers)Lei Zhang (2 shared papers)Xinning Yang (4 shared papers)Lei Zhang (1 shared paper)Jayabharathi Vaidyanathan (1 shared paper)Yuichi Sugiyama (2 shared papers)
Journals: The Journal of Clinical Pharmacology (19 papers)Clinical Pharmacology & Therapeutics (6 papers)Drug Metabolism and Disposition (3 papers)Journal of Pharmacy and Pharmacology (2 papers)CPT Pharmacometrics & Systems Pharmacology (2 papers)
Partner nations: United States United Kingdom India

In The Last Decade

Vikram Arya

49 papers receiving 1.1k citations

Peers

Countries citing papers authored by Vikram Arya

Since Specialization

Citations

This map shows the geographic impact of Vikram Arya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikram Arya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikram Arya more than expected).

Fields of papers citing papers by Vikram Arya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikram Arya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikram Arya. The network helps show where Vikram Arya may publish in the future.

Co-authors

The 25 scholars most cited alongside Vikram Arya, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Vikram Arya Line = papers co-authored together Vikram Arya links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug‐Drug Interaction Evaluation: Perspectives From the International Transporter Consortium Clinical Pharmacology & Therapeutics ·Xiaoyan Chu, Mingxiang Liao, Hong Shen, Kenta Yoshida, Arik A. Zur, Vikram Arya, Aleksandra Galetin, Kathleen M. Giacomini, Imad Hanna, Hiroyuki Kusuhara, Yurong Lai, David Rodrigues, Yuichi Sugiyama, Maciej J. Zamek‐Gliszczynski, Lei Zhang	2018	161
2	Population Pharmacokinetics and Pharmacodynamics of Ciclesonide The Journal of Clinical Pharmacology ·Shashank Rohatagi, Vikram Arya, Karl Zech, R. Nave, Günther Hochhaus, Bradford K. Jensen, Jeffrey S. Barrett	2003	92
3	Comparing Various In Vitro Prediction Criteria to Assess the Potential of a New Molecular Entity to Inhibit Organic Anion Transporting Polypeptide 1B1 The Journal of Clinical Pharmacology ·Jayabharathi Vaidyanathan, Kenta Yoshida, Vikram Arya, Lei Zhang	2016	89
4	Evaluation of Exposure Change of Nonrenally Eliminated Drugs in Patients With Chronic Kidney Disease Using Physiologically Based Pharmacokinetic Modeling and Simulation The Journal of Clinical Pharmacology ·Ping Zhao, Manuela de Lima Toccafondo Vieira, Joseph A. Grillo, Pengfei Song, Ta‐Chen Wu, Jenny Zheng, Vikram Arya, Eva Gil Berglund, Arthur J. Atkinson, Yuichi Sugiyama, K. Sandy Pang, Kellie S. Reynolds, Nicholas M. P. King, Lei Zhang, Lawrence J. Lesko, Shiew‐Mei Huang	2012	80
5	Evaluation of transporters in drug development: Current status and contemporary issues Advanced Drug Delivery Reviews ·Sue‐Chih Lee, Vikram Arya, Xinning Yang, Donna A. Volpe, Lei Zhang	2017	65
6	Slow Release Formulations of Inhaled Rifampin The AAPS Journal ·Intira Coowanitwong, Vikram Arya, Poj Kulvanich, Günther Hochhaus	2008	60
7	Review of P‐gp Inhibition Data in Recently Approved New Drug Applications: Utility of the Proposed [I₁]/IC₅₀ and [I₂]/IC₅₀ Criteria in the P‐gp Decision Tree The Journal of Clinical Pharmacology ·Sheetal Agarwal, Vikram Arya, Lei Zhang	2012	46
8	The Application of Physiologically Based Pharmacokinetic Modeling to Predict the Role of Drug Transporters: Scientific and Regulatory Perspectives The Journal of Clinical Pharmacology ·Yuzhuo Pan, Vicky Hsu, Manuela Grimstein, Lei Zhang, Vikram Arya, Vikram Sinha, Joseph A. Grillo, Ping Zhao	2016	39
9	Clinical Pharmacology of RNA Interference–Based Therapeutics: A Summary Based on Food and Drug Administration–Approved Small Interfering RNAs Drug Metabolism and Disposition ·Xing Jing, Vikram Arya, Hobart Rogers	2022	36
10	The role of dietary polyphenols in inflammatory bowel disease: A possible clue on the molecular mechanisms involved in the prevention of immune and inflammatory reactions Journal of Food Biochemistry ·Vikram Arya, S.K. Kanthlal, Linda Galasso	2020	33
11	Regulatory Perspectives on Designing Pharmacokinetic Studies and Optimizing Labeling Recommendations for Patients With Chronic Kidney Disease The Journal of Clinical Pharmacology ·Lei Zhang, Nancy Xu, Shen Xiao, Vikram Arya, Ping Zhao, Lawrence J. Lesko, Shiew‐Mei Huang	2012	27
12	Cobicistat-containing antiretroviral regimens are not recommended during pregnancy AIDS ·Sarita D. Boyd, Mario R. Sampson, Prabha Viswanathan, Kimberly Struble, Vikram Arya, Adam Sherwat	2019	25
13	Age effects on the pharmacokinetics of tityustoxin from Tityus serrulatus scorpion venom in rats Brazilian Journal of Medical and Biological Research ·E. A. Nunan, Vikram Arya, Günther Hochhaus, Valbert Nascimento Cardoso, Tasso Moraes-Santos	2004	24
14	Mechanistic Models as Framework for Understanding Biomarker Disposition: Prediction of Creatinine‐Drug Interactions CPT Pharmacometrics & Systems Pharmacology ·Daniel Scotcher, Vikram Arya, Xinning Yang, Ping Zhao, Lei Zhang, Shiew‐Mei Huang, Amin Rostami‐Hodjegan, Aleksandra Galetin	2020	22
15	The Role of Clinical Pharmacology in Supporting the Emergency Use Authorization of an Unapproved Anti-Influenza Drug, Peramivir Clinical Pharmacology & Therapeutics ·Vikram Arya, W W Carter, Sarah Robertson	2010	21
16	CONTRARY TO ADULT, NEONATAL RATS SHOW PRONOUNCED BRAIN UPTAKE OF CORTICOSTEROIDS Drug Metabolism and Disposition ·Vikram Arya, Vincent G. DeMarco, Manish Issar, Günther Hochhaus	2006	20
17	A Novel Physiologically Based Model of Creatinine Renal Disposition to Integrate Current Knowledge of Systems Parameters and Clinical Observations CPT Pharmacometrics & Systems Pharmacology ·Daniel Scotcher, Vikram Arya, Xinning Yang, Ping Zhao, Lei Zhang, Shiew‐Mei Huang, Amin Rostami‐Hodjegan, Aleksandra Galetin	2020	18
18	Brain permeability of inhaled corticosteroids Journal of Pharmacy and Pharmacology ·Vikram Arya, Manish Issar, Yaning Wang, Günther Hochhaus, (unknown)	2005	17
19	Whole Body PBPK Modeling of Remdesivir and Its Metabolites to Aid in Estimating Active Metabolite Exposure in the Lung and Liver in Patients With Organ Dysfunction Clinical Pharmacology & Therapeutics ·Jianghong Fan, Yuching Yang, Manuela Grimstein, Xinyuan Zhang, Eliford Kitabi, Justin Earp, Vikram Arya, Kellie S. Reynolds, Hao Zhu, Yaning Wang	2021	16
20	Using Endogenous Biomarkers to Derisk Assessment of Transporter‐Mediated Drug‐Drug Interactions: A Scientific Perspective The Journal of Clinical Pharmacology ·Vikram Arya, Kellie S. Reynolds, Xinning Yang	2022	16

About Vikram Arya

Vikram Arya is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology, Infectious Diseases, Oncology and Molecular Biology, having authored 50 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (15 papers), Drug Transport and Resistance Mechanisms (13 papers), Pharmacological Effects and Toxicity Studies (12 papers), HIV/AIDS drug development and treatment (10 papers), Pharmaceutical studies and practices (5 papers), HIV/AIDS Research and Interventions (4 papers), HIV Research and Treatment (4 papers) and COVID-19 Clinical Research Studies (4 papers). The work is most often cited by research in Pharmacology (280 citations), Pediatrics, Perinatology and Child Health (359 citations), Oncology (479 citations), Pharmaceutical Science (70 citations) and Transplantation (21 citations). Vikram Arya has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Günther Hochhaus, Kenta Yoshida, Lei Zhang, Lei Zhang, Xinning Yang, Lei Zhang, Jayabharathi Vaidyanathan, Yuichi Sugiyama, Aleksandra Galetin and Kellie S. Reynolds. Their work appears in journals such as The Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, Drug Metabolism and Disposition, Journal of Pharmacy and Pharmacology and CPT Pharmacometrics & Systems Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact